Breast Cancer News and Research

Latest Breast Cancer News and Research

Breast cancer drug bevacizumab slows progression but has no overall survival benefit

The cancer drug bevacizumab (Avastin®) offers only a modest benefit in prolonging disease progression in patients with advanced stage breast cancer, according to a systematic review by Cochrane researchers. The researchers assessed the efficacy of bevacizumab in combination with chemotherapy, an established cancer treatment in this indication, and found no overall survival benefit when adding bevacizumab to chemotherapy.

11 Jul 2012

New approach integrates rational drug design with supramolecular nanochemistry in cancer treatment

Researchers at Brigham and Women's Hospital (BWH) are the first to report a new approach that integrates rational drug design with supramolecular nanochemistry in cancer treatment.

11 Jul 2012

Book explains complex world of personalized medicine

Personalized medicine has promised to radically change the way we look at health and disease. Talk of tailored drug therapies and early detection of cancer has captured the attention of scientists and lay people alike. So when will patients start to reap the benefits of this medical revolution?

11 Jul 2012

Biomarkers predict benefit of targeted therapy in metastatic renal-cell cancer

In metastatic renal-cell cancer, the level of cytokines and angiogenic factors identify those patients with an aggressive disease course who derive the greatest benefit from treatment with the molecular-targeted therapy pazopanib, a retrospective analysis of clinical trials shows.

10 Jul 2012

Scientists develop novel anticancer drug designed to travel through the bloodstream

Scientists at the Johns Hopkins Kimmel Cancer Center, working with Danish researchers, have developed a novel anticancer drug designed to travel -- undetected by normal cells -- through the bloodstream until activated by specific cancer proteins.

10 Jul 2012

RA patients do not receive fewer cancer screening tests than general population: Study

New research reveals that rheumatoid arthritis (RA) patients do not receive fewer cancer screening tests than the general population. Results of the study, funded in part by grants from the National Institutes of Health (NIH) and published in Arthritis & Rheumatism, a journal of the American College of Rheumatology (ACR), found that RA and non-RA patients receive routine screening for breast, cervical, and colon cancer at similar rates.

10 Jul 2012

MammaPrint more cost-effective and clinically-useful test than Oncotype DX

New research from University of the Sciences' Mayes College of Healthcare Business and Policy suggests that MammaPrint - a gene expression profiling (GEP) test used to identify whether women with early-stage breast cancer would benefit from chemotherapy - is the more cost-effective and clinically-useful test than the most frequently used GEP in practice in the United States today.

10 Jul 2012

Protein interactions outside breast cancer cells can permanently stop proliferation

Protein interactions outside breast cancer cells can send signals to the cancer cells to permanently stop proliferating, a new study showed in the School of Medicine at The University of Texas Health Science Center San Antonio.

10 Jul 2012

Hormone therapy still an acceptable treatment for menopausal symptoms: New joint statement

After 10 years of debate regarding the risks and benefits of hormone therapy, 15 top medical organizations have come together to issue a statement of agreement regarding the benefits of hormone therapy for symptomatic menopausal women. It was July 9, 2002, when the controversial, highly publicized Women's Health Initiative (WHI) published its assessment of hormone therapy for the prevention of chronic disease and concluded that risks exceeded benefits.

10 Jul 2012

Study determines risk of young-onset breast cancer after use of ovulation-stimulating fertility drugs

Women using fertility drugs who did not conceive a 10-plus week pregnancy were at a statistically significant reduced risk of breast cancer compared to nonusers; however, women using the drugs who conceived a 10-plus week pregnancy had a statistically significant increased risk of breast cancer compared to unsuccessfully treated women, but a comparable risk to nonusers, according to a study published July 6 in the Journal of The National Cancer Institute.

7 Jul 2012

New optical microscope identifies rare breast cancer cells

The ability to distinguish and isolate rare cells from among a large population of assorted cells has become increasingly important for the early detection of disease and for monitoring disease treatments.

7 Jul 2012

NewYork-Presbyterian/WCMC first in N.Y. City to offer INTRABEAM radiotherapy

NewYork-Presbyterian Hospital/Weill Cornell Medical Center is the first and only hospital in the five boroughs of New York City to offer women with early stage breast cancer INTRABEAM radiotherapy, an innovative radiation treatment delivered in a single dose at the time of surgery.

6 Jul 2012

Insight into understanding IDH mediated disease

Agios Pharmaceuticals, the leading biopharmaceutical company focused on discovering and developing novel drugs in cancer metabolism, announced today the publication of a new study that provides further evidence of the link between a mutated metabolic enzyme and acute myeloid leukemia (AML), one of the most common types of leukemia in adults.

6 Jul 2012

The Center for Cancer Support and Education in Arlington to receive $10,000 ASTRO grant

As part of an initiative to give back to cancer communities in the cities visited during its annual scientific meetings, the American Society for Radiation Oncology (ASTRO) is recognizing The Center for Cancer Support and Education (The Center) in Arlington, Mass., for its efforts to empower and support people touched by cancer, their caregivers and loved ones.

6 Jul 2012

Cancer Therapeutics announces validation and performance of CTx-294886 plus Avastin

5 Jul 2012

Scientists identify causative link between oncometabolite and onset of AML

A team of international scientists led by principal investigator Dr. Tak Mak at the Princess Margaret Cancer Centre, University Health Network, has identified a causative link between the product of a mutated metabolic enzyme and the onset of acute myeloid leukemia (AML), one of the most common types of leukemia in adults.

5 Jul 2012

Single dose breast cancer treatment helps forego 6-7 week radiation regimen

5 Jul 2012

Cancer Therapeutics reveals proof of concept for second development drug

Cancer Therapeutics, a company focused on translating cancer biology research into novel treatments for cancer, today announced the validation and performance of a new targeted drug, CTx-294886, in combination with Avastin™ (bevacizumab – Genentech/Roche) in a preclinical model of breast cancer. At the same time the Company announced that it has developed a new High Throughput Screening (HTS) platform for the identification of small molecule inhibitors of protein ubiquitination, a key element in the essential cellular process of protein homeostasis, which is an exciting new target pathway for cancer treatment. Both scientific developments will be presented as posters at the EACR conference in Barcelona Spain on July 7-10 2012.

4 Jul 2012

Italy's first successful pregnancy and delivery following transplantation of ovarian tissue

Although the first successful preservation of fertility from the freezing, thawing and grafting of ovarian tissue was reported eight years ago, the technique has remained experimental and confined to a few specialist centres. Now, with the announcement of a first pregnancy (and subsequent live birth) in Italy following the transplantation of ovarian tissue, there are indications that fertility preservation is moving into the mainstream of reproductive medicine and into a greater number of centres.

4 Jul 2012

Former President Bush in Zambia, Botswana to promote Pink Ribbon Red Ribbon initiative to fight cervical cancer

Former President George W. Bush and former first lady Laura Bush are traveling in Zambia and Botswana this week to promote "the Pink Ribbon Red Ribbon initiative spearheaded by his foundation that seeks to expand cervical and breast cancer screening and treatment in sub-Saharan Africa," CNN reports.

4 Jul 2012

Breast Cancer News and Research

Latest Breast Cancer News and Research

Breast cancer drug bevacizumab slows progression but has no overall survival benefit

New approach integrates rational drug design with supramolecular nanochemistry in cancer treatment

Book explains complex world of personalized medicine

Biomarkers predict benefit of targeted therapy in metastatic renal-cell cancer

Scientists develop novel anticancer drug designed to travel through the bloodstream

RA patients do not receive fewer cancer screening tests than general population: Study

MammaPrint more cost-effective and clinically-useful test than Oncotype DX

Protein interactions outside breast cancer cells can permanently stop proliferation

Hormone therapy still an acceptable treatment for menopausal symptoms: New joint statement

Study determines risk of young-onset breast cancer after use of ovulation-stimulating fertility drugs

New optical microscope identifies rare breast cancer cells

NewYork-Presbyterian/WCMC first in N.Y. City to offer INTRABEAM radiotherapy

Insight into understanding IDH mediated disease

The Center for Cancer Support and Education in Arlington to receive $10,000 ASTRO grant

Cancer Therapeutics announces validation and performance of CTx-294886 plus Avastin

Scientists identify causative link between oncometabolite and onset of AML

Single dose breast cancer treatment helps forego 6-7 week radiation regimen

Cancer Therapeutics reveals proof of concept for second development drug

Italy's first successful pregnancy and delivery following transplantation of ovarian tissue

Former President Bush in Zambia, Botswana to promote Pink Ribbon Red Ribbon initiative to fight cervical cancer

Industry Focus eBook - Oncology (1st Edition) eBook

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Breast Cancer News and Research

Latest Breast Cancer News and Research

Industry Focus eBook - Oncology (1st Edition) eBook

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Newsletters you may be interested in